Sobi receives SFDA approval for Orfadin capsules

Specialist healthcare company Swedish Orphan Biovitrum (Sobi) has received approval from the Saudi Food and Drug Administration (SFDA) for Orfadin (nitisinone) capsules in strengths of 2mg, 5mg, 10mg and 20mg.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news